Cellular Orthopedics Blog

A disclaimer at the get-go. The title of this Blog was influenced by my repeat viewing the other night, when I became tired of news and sports, of the Good, the Bad, and the Ugly, about 40-odd years after my first watch. The penetrating music was never forgotten. The...

Looking forward in 2023, our first clinical day in the new offices at 618 West Fulton Street, Chicago, Illinois 60661 is Tuesday, January 10. The number to use to schedule a visit is (312) 475-1893. Our Glenview office is scheduled to open in March of this year. The...

While surfing the internet this morning, I was amazed by the multiple websites marketing umbilical cord, placental tissue, and amniotic fluid-derived stem cells for every disease known to mankind; but then I realized, you would have to leave town for some foreign...

As announced in our last Blog and via letters to our patients this past week, our Chicago office will move to 618 West Fulton, 60661 as of January 1, 2023. Our team is working out the details concerning patient parking, electronic medical records, and so on. Until...

You may pick up on the theme of this Blog either in Ecclesiastes 3:1 or by listening to the music of Pete Seeger so Turn! Turn! Turn! over the holiday period. No matter your preference, I will be moving my offices to 618 West Fulton Street, Chicago, Illinois 60661 as...

Due to the Federal District Court ruling in the CSCTC/CSN case in August of this year, it appears that FDA has no jurisdiction in autologous adipose cell therapy, including cell culture expanded cells. Many questions on interpretation so here is the link to the ruling...

Last Thursday, I stopped doing the talk; I took the walk. As readers of this Blog are aware, I have not been spared from the ravages of aging joints, having enjoyed a very active recreational profile since childhood. My pain generated by the joint inflammation as a...

The standard of care in regenerative medicine and cellular orthopedics has been, and continues to be, your Concentrated Stem Cells. My research and resulting evidence continue to support our ongoing clinical focus; whether the stem cells are harvested from bone marrow...

For the past year or so, I have been including in my Blogs, the possibility of a second Adipose Based Stem Cell Clinical Trial sponsored by the same group as the first stem cell trial completed over 18 months ago. Personalized Stem Cells, Inc. (PSC), for whom I served...

J Bone Joint Surg Am 2020 Mar 18;102(6):468-476. 294 Knee Replacements in a Study Group of 3,417 were deemed “likely” Inappropriate According to the Journal of Bone and Joint Surgery, it is clinically relevant to ensure that the patient is actually ready for joint...

Two weekends ago, a retired vascular surgeon posed the question to me: hence the title of this Blog. In response, I cited a Tale of two sisters, and I will repeat the anecdote as I had answered his question. The wife of a foot and ankle surgeon manages the related...

California Clinic Chain Wins Its Case with the FDA A big event happened that may shake up the FDA regulation of autologous orthobiologics. What Happened? The court ruling on August 30th by the US District Court (Central District of California) was in favor of the...